EIA (Enzyme immunoassay) Enzyme immunoassay The measurement principle is the same as RIA; an antigen-antibody reaction is performed using an enzyme-labeled antigen or antibody as a labeling substance, and a chromogenic substrate is added to detect enzyme activity. How to measure.
Less than 0.80 Negative Criteria: See below
Human parvovirus B19 IgM
Serum
0.2
S09 ↓ A00
2-4
Enzyme immunoassay(EIA)
EIA (Enzyme immunoassay) Enzyme immunoassay The measurement principle is the same as RIA; an antigen-antibody reaction is performed using an enzyme-labeled antigen or antibody as a labeling substance, and a chromogenic substrate is added to detect enzyme activity. How to measure.
Less than 0.80 Negative Criteria: See below
Human parvovirus B19 DNA qualitative
Serum
0.7
S09 ↓ ARR
(3 month)
3-5
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Human papillomavirus DNA (type 16, type 18, other high-risk groups)
Uterine cervix
3.0
V41
2-4
PCR (Real Time PCR)
Real-time PCR A type of nucleic acid amplification method based on the basic principle of PCR, which uses oligonucleotides that emit fluorescence upon decomposition to quantify target nucleic acids in real time by checking the fluorescent signal at each PCR cycle. A measurement method that enables
HPV type 16 negative HPV type 18 negative Other high-risk groups negative
Human papillomavirus DNA (high-risk group)
See below
V60
下記参照
3-5
Liquid phase (nucleic acid) hybridization
Liquid phase (nucleic acid) hybridization rRNA is released in the liquid phase, hybridization is performed using a DNA probe labeled with a chemiluminescent substance, the hybrid is adsorbed to a separation agent, and then detected by chemiluminescence method.
Negative
Human papillomavirus DNA (high-risk group) (LBC)
See below
V41
(1 month)
3-5
Liquid phase (nucleic acid) hybridization
Liquid phase (nucleic acid) hybridization rRNA is released in the liquid phase, hybridization is performed using a DNA probe labeled with a chemiluminescent substance, the hybrid is adsorbed to a separation agent, and then detected by chemiluminescence method.
Negative
Human papillomavirus (HPV) genotyping
Uterine cervix
V41
(28 days)
4-6
PCR-rSSO method
Negative
Human papillomavirus DNA (low-risk group)
See below
V60
下記参照
4-10
Liquid phase (nucleic acid) hybridization
Liquid phase (nucleic acid) hybridization rRNA is released in the liquid phase, hybridization is performed using a DNA probe labeled with a chemiluminescent substance, the hybrid is adsorbed to a separation agent, and then detected by chemiluminescence method.
Negative
adenovirus
Serum
0.3
S09 ↓ A00
4-6
CF (complement fixation reaction)
CF (Complement fixation) Complement fixation reaction A method that utilizes the fact that complement binds to antigen-antibody complexes and causes a hemolytic reaction. Sensitized red blood cells with hemolysin bound to red blood cells cause hemolysis when complement binds to them, but if antigen-antibody complexes are present, complement is consumed and hemolysis is prevented. Determine existence.
Less than 4(times)
Adenovirus DNA qualitative
Conjunctival swab liquid
ARR
(3 month)
3-9
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Adenovirus DNA qualitative
Partial urine
0.7
ARR
(1 month)
3-9
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Adenovirus DNA qualitative
Feces
500mg
F00
(1 month)
3-9
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Adenovirus type 1
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
Adenovirus type 2
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
Adenovirus type 3
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
Adenovirus type 4
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
Adenovirus type 5
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
Adenovirus type 6
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
Adenovirus type 7
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
Adenovirus type 11
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
Adenovirus type 19
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
Adenovirus type 21
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
Adenovirus type 37
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
Herpes simplex virus specific antigen
Smear
2 sheets
V30
2-4
FA
FA (Fluorescent antibody method) Fluorescent antibody method A method in which an antigen-antibody reaction is performed against the target antigen using an antibody labeled with a fluorescent dye, and the fluorescence intensity is measured under a fluorescence microscope. There is a direct method in which an antibody labeled with a fluorescent dye is reacted directly, and an indirect method in which the antibody is reacted with an antigen and then a secondary reaction is performed with an antibody labeled with a fluorescent dye.
Herpes simplex virus type 1 antigen (FA) negative Herpes simplex virus type 2 antigen (FA) negative
Herpes simplex virus
Serum
0.3
S09 ↓ A00
4-6
CF (complement fixation reaction)
CF (Complement fixation) Complement fixation reaction A method that utilizes the fact that complement binds to antigen-antibody complexes and causes a hemolytic reaction. Sensitized red blood cells with hemolysin bound to red blood cells cause hemolysis when complement binds to them, but if antigen-antibody complexes are present, complement is consumed and hemolysis is prevented. Determine existence.
Less than 4(times)
Herpes simplex virus IgG
Serum
0.2
S09 ↓ A00
2-4
Enzyme immunoassay(EIA)
EIA (Enzyme immunoassay) Enzyme immunoassay The measurement principle is the same as RIA; an antigen-antibody reaction is performed using an enzyme-labeled antigen or antibody as a labeling substance, and a chromogenic substrate is added to detect enzyme activity. How to measure.
Less than 2.0 Negative Criteria: See below
Herpes simplex virus IgG
Cerebrospinal fluid
0.4
A00
2-4
Enzyme immunoassay(EIA)
EIA (Enzyme immunoassay) Enzyme immunoassay The measurement principle is the same as RIA; an antigen-antibody reaction is performed using an enzyme-labeled antigen or antibody as a labeling substance, and a chromogenic substrate is added to detect enzyme activity. How to measure.
Less than 0.20 Negative Criteria: See below
Herpes simplex virus IgM
Serum
0.2
S09 ↓ A00
2-4
Enzyme immunoassay(EIA)
EIA (Enzyme immunoassay) Enzyme immunoassay The measurement principle is the same as RIA; an antigen-antibody reaction is performed using an enzyme-labeled antigen or antibody as a labeling substance, and a chromogenic substrate is added to detect enzyme activity. How to measure.
Less than 0.80 Negative Criteria: See below
Herpes simplex virus DNA Qualitative
Blood (EDTA-2Na added)
2
PN5
(10 days)
3-5
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Herpes simplex virus DNA Qualitative
Cerebrospinal fluid
0.7
ARR
(3 month)
3-5
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Herpes simplex virus DNA Qualitative
Affected area swab fluid
ARR
(3 month)
3-5
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Herpes simplex virus DNA Qualitative
tissue
50mg
ARR
(3 month)
3-5
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Herpes simplex virus DNA quantification
Blood (EDTA-2Na added)
5.0
PN7
(10 days)
2-4
PCR (Real Time PCR)
Real-time PCR A type of nucleic acid amplification method based on the basic principle of PCR, which uses oligonucleotides that emit fluorescence upon decomposition to quantify target nucleic acids in real time by checking the fluorescent signal at each PCR cycle. A measurement method that enables
Less than 2.0×101(copy/106cells)
Herpes simplex virus DNA quantification
Cerebrospinal fluid
0.7
ARR
(1 month)
2-4
PCR (Real Time PCR)
Real-time PCR A type of nucleic acid amplification method based on the basic principle of PCR, which uses oligonucleotides that emit fluorescence upon decomposition to quantify target nucleic acids in real time by checking the fluorescent signal at each PCR cycle. A measurement method that enables
Less than 1.0×102 (copy/mL)
Herpes simplex virus type 1
Serum
0.2
S09 ↓ A00
6-12
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(times)
Herpes simplex virus type 2
Serum
0.2
S09 ↓ A00
6-12
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(times)
Herpes simplex virus type 1 and 2 - IgG
Serum
0.6
S09 ↓ A00
(15 days)
3-5
FIA
FIA (Fluorescence Immunoassay) Fluorescence immunoassay method After reacting a target substance to the immobilized antigen, a secondary reaction is performed with an antibody or antigen labeled with a fluorescent substance, and the fluorescence intensity is measured.
Less than 0.9 (AI) Judgment criteria: See below
Varicella-zoster virus antigen
Smear
2 sheets
V30
2-4
FA
FA (Fluorescent antibody method) Fluorescent antibody method A method in which an antigen-antibody reaction is performed against the target antigen using an antibody labeled with a fluorescent dye, and the fluorescence intensity is measured under a fluorescence microscope. There is a direct method in which an antibody labeled with a fluorescent dye is reacted directly, and an indirect method in which the antibody is reacted with an antigen and then a secondary reaction is performed with an antibody labeled with a fluorescent dye.
Negative
Varicella-zoster virus
Serum
0.3
S09 ↓ A00
4-6
CF (complement fixation reaction)
CF (Complement fixation) Complement fixation reaction A method that utilizes the fact that complement binds to antigen-antibody complexes and causes a hemolytic reaction. Sensitized red blood cells with hemolysin bound to red blood cells cause hemolysis when complement binds to them, but if antigen-antibody complexes are present, complement is consumed and hemolysis is prevented. Determine existence.
Less than 4(times)
Varicella-zoster virus IgG
Serum
0.2
S09 ↓ A00
2-4
Enzyme immunoassay(EIA)
EIA (Enzyme immunoassay) Enzyme immunoassay The measurement principle is the same as RIA; an antigen-antibody reaction is performed using an enzyme-labeled antigen or antibody as a labeling substance, and a chromogenic substrate is added to detect enzyme activity. How to measure.
Less than 2.0 Negative Criteria: See below
Varicella-zoster virus IgM
Serum
0.2
S09 ↓ A00
2-4
Enzyme immunoassay(EIA)
EIA (Enzyme immunoassay) Enzyme immunoassay The measurement principle is the same as RIA; an antigen-antibody reaction is performed using an enzyme-labeled antigen or antibody as a labeling substance, and a chromogenic substrate is added to detect enzyme activity. How to measure.
Less than 0.80 Negative Criteria: See below
Varicella-zoster virus DNA Qualitative
Affected area swab fluid
ARR
(3 month)
3-5
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Varicella-zoster virus DNA Qualitative
Blood (EDTA-2Na added)
2
PN5
(10 days)
3-5
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Varicella-zoster virus DNA Qualitative
Cerebrospinal fluid
0.7
ARR
(3 month)
3-5
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Varicella-zoster virus DNA quantification
Cerebrospinal fluid
0.7
ARR
(1 month)
2-4
PCR (Real Time PCR)
Real-time PCR A type of nucleic acid amplification method based on the basic principle of PCR, which uses oligonucleotides that emit fluorescence upon decomposition to quantify target nucleic acids in real time by checking the fluorescent signal at each PCR cycle. A measurement method that enables
Less than 1.0×102 (copy/mL)
Varicella-zoster virus DNA quantification
Blood (EDTA-2Na added)
5.0
PN7
2-4
PCR (Real Time PCR)
Real-time PCR A type of nucleic acid amplification method based on the basic principle of PCR, which uses oligonucleotides that emit fluorescence upon decomposition to quantify target nucleic acids in real time by checking the fluorescent signal at each PCR cycle. A measurement method that enables
Less than 2.0×101 (copy/106cells)
Cytomegalovirus pp65 antigen (C7-HRP)
Blood (EDTA-2Na added)
3
PN5
2-4
direct enzyme immunoassay
Enzyme-antibody method A method in which an antigen-antibody reaction is performed against the target antigen using an enzyme-labeled antibody, and a chromogenic substrate is added to measure the enzyme activity. There is a direct method in which an enzyme-labeled antibody is reacted directly, and an indirect method in which an unlabeled antibody is reacted with the antigen and then a secondary reaction is performed with an enzyme-labeled antibody.
Negative
Cytomegalovirus
Serum
0.3
S09 ↓ A00
4-6
CF (complement fixation reaction)
CF (Complement fixation) Complement fixation reaction A method that utilizes the fact that complement binds to antigen-antibody complexes and causes a hemolytic reaction. Sensitized red blood cells with hemolysin bound to red blood cells cause hemolysis when complement binds to them, but if antigen-antibody complexes are present, complement is consumed and hemolysis is prevented. Determine existence.
Less than 4(times)
Cytomegalovirus IgG
Serum
0.5
S09 ↓ A00
2-4
CLIA
CLIA (Chemiluminescent immunoassay) Chemiluminescent immunoassay method After reacting the antigen with the immobilized antibody, the antibody labeled with a chemiluminescent substance is caused to react with the antigen for a second time to generate chemiluminescent A method for measuring the luminescence intensity of substances.
Less than 6.0 Negative (AU/mL) Criteria: See below
Cytomegalovirus IgM
Serum
0.5
S09 ↓ A00
2-4
CLIA
CLIA (Chemiluminescent immunoassay) Chemiluminescent immunoassay method After reacting the antigen with the immobilized antibody, the antibody labeled with a chemiluminescent substance is caused to react with the antigen for a second time to generate chemiluminescent A method for measuring the luminescence intensity of substances.
Less than 0.85 Negative (Index) Judgment criteria: See below
Cytomegalovirus DNA Qualitative
Blood (EDTA-2Na added)
2
PN5
(10 days)
3-5
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Cytomegalovirus DNA Qualitative
Cerebrospinal fluid
0.7
ARR
(3 month)
3-5
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Cytomegalovirus DNA Qualitative
Affected area swab fluid
ARR
(3 month)
3-5
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Cytomegalovirus DNA Qualitative
Partial urine
0.7
ARR
(3 month)
3-5
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Cytomegalovirus DNA Qualitative
tissue
50mg
ARR
(3 month)
3-5
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Unlike the PCR method, this method amplifies nucleic acids at a constant temperature using a strand displacement DNA synthetase.
Negative
Cytomegalovirus nucleic acid quantification
Plasma
1.8
PSF
(84 days)
2-4
PCR (Real Time PCR)
Real-time PCR A type of nucleic acid amplification method based on the basic principle of PCR, which uses oligonucleotides that emit fluorescence upon decomposition to quantify target nucleic acids in real time by checking the fluorescent signal at each PCR cycle. A measurement method that enables
Not detected (IU/mL)
EB virus DNA quantification
Blood (EDTA-2Na added)
2
PN5
(28 days)
2-4
PCR (Real Time PCR)
Real-time PCR A type of nucleic acid amplification method based on the basic principle of PCR, which uses oligonucleotides that emit fluorescence upon decomposition to quantify target nucleic acids in real time by checking the fluorescent signal at each PCR cycle. A measurement method that enables
Not detected (Log IU/mL)
EB virus DNA quantification
Plasma
2
PN5 ↓ ARR
(28 days)
2-4
PCR (Real Time PCR)
Real-time PCR A type of nucleic acid amplification method based on the basic principle of PCR, which uses oligonucleotides that emit fluorescence upon decomposition to quantify target nucleic acids in real time by checking the fluorescent signal at each PCR cycle. A measurement method that enables
Not detected (Log IU/mL)
EB virus DNA (Clonality)
Blood (EDTA-2Na added)
7
PN7
(10 days)
17-23
Southern Blot Hybridization
Southern Blot Hybridization A technique to detect a specific gene by the following procedures: After restriction enzyme digestion of DNA, DNA is isolated and denatured to a single-stranded form with electrophoresis. Using capillary action, the singlestranded DNA is transferred to a nylon membrane and hybridized with a target probe to detect the target gene. This technique is used for analysis of abnormal changes in DNA in a quantitative and qualitative manner.
EB virus DNA (Clonality)
tissue
250mg
ARR
(3 month)
17-23
Southern Blot Hybridization
Southern Blot Hybridization A technique to detect a specific gene by the following procedures: After restriction enzyme digestion of DNA, DNA is isolated and denatured to a single-stranded form with electrophoresis. Using capillary action, the singlestranded DNA is transferred to a nylon membrane and hybridized with a target probe to detect the target gene. This technique is used for analysis of abnormal changes in DNA in a quantitative and qualitative manner.
EB virus Anti-VCA IgG
Serum
0.2
S09 ↓ A00
2-4
Enzyme immunoassay(EIA)
EIA (Enzyme immunoassay) Enzyme immunoassay The measurement principle is the same as RIA; an antigen-antibody reaction is performed using an enzyme-labeled antigen or antibody as a labeling substance, and a chromogenic substrate is added to detect enzyme activity. How to measure.
Less than 0.5 Negative Criteria: See below
EB virus Anti-VCA IgG
Serum
0.2
S09 ↓ A00
3-5
FA (fluorescent antibody method)
FA (Fluorescent antibody method) Fluorescent antibody method A method in which an antigen-antibody reaction is performed against the target antigen using an antibody labeled with a fluorescent dye, and the fluorescence intensity is measured under a fluorescence microscope. There is a direct method in which an antibody labeled with a fluorescent dye is reacted directly, and an indirect method in which the antibody is reacted with an antigen and then a secondary reaction is performed with an antibody labeled with a fluorescent dye.
Less than 10 (times)
EB virus Anti-VCA IgM
Serum
0.2
S09 ↓ A00
2-4
Enzyme immunoassay(EIA)
EIA (Enzyme immunoassay) Enzyme immunoassay The measurement principle is the same as RIA; an antigen-antibody reaction is performed using an enzyme-labeled antigen or antibody as a labeling substance, and a chromogenic substrate is added to detect enzyme activity. How to measure.
Less than 0.5 Negative Criteria: See below
EB virus Anti-VCA IgM
Serum
0.2
S09 ↓ A00
3-5
FA (fluorescent antibody method)
FA (Fluorescent antibody method) Fluorescent antibody method A method in which an antigen-antibody reaction is performed against the target antigen using an antibody labeled with a fluorescent dye, and the fluorescence intensity is measured under a fluorescence microscope. There is a direct method in which an antibody labeled with a fluorescent dye is reacted directly, and an indirect method in which the antibody is reacted with an antigen and then a secondary reaction is performed with an antibody labeled with a fluorescent dye.
Less than 10 (times)
EB virus Anti-VCA IgA
Serum
0.2
S09 ↓ A00
3-5
FA (fluorescent antibody method)
FA (Fluorescent antibody method) Fluorescent antibody method A method in which an antigen-antibody reaction is performed against the target antigen using an antibody labeled with a fluorescent dye, and the fluorescence intensity is measured under a fluorescence microscope. There is a direct method in which an antibody labeled with a fluorescent dye is reacted directly, and an indirect method in which the antibody is reacted with an antigen and then a secondary reaction is performed with an antibody labeled with a fluorescent dye.
Less than 10 (times)
EB virus Anti-EA IgG
Serum
0.2
S09 ↓ A00
2-4
Enzyme immunoassay(EIA)
EIA (Enzyme immunoassay) Enzyme immunoassay The measurement principle is the same as RIA; an antigen-antibody reaction is performed using an enzyme-labeled antigen or antibody as a labeling substance, and a chromogenic substrate is added to detect enzyme activity. How to measure.
Less than 0.5 Negative Criteria: See below
EB virus Anti-EA-DR IgG
Serum
0.2
S09 ↓ A00
3-5
FA (fluorescent antibody method)
FA (Fluorescent antibody method) Fluorescent antibody method A method in which an antigen-antibody reaction is performed against the target antigen using an antibody labeled with a fluorescent dye, and the fluorescence intensity is measured under a fluorescence microscope. There is a direct method in which an antibody labeled with a fluorescent dye is reacted directly, and an indirect method in which the antibody is reacted with an antigen and then a secondary reaction is performed with an antibody labeled with a fluorescent dye.
Less than 10 (times)
EB virus Anti-EA-DR IgA
Serum
0.2
S09 ↓ A00
3-5
FA (fluorescent antibody method)
FA (Fluorescent antibody method) Fluorescent antibody method A method in which an antigen-antibody reaction is performed against the target antigen using an antibody labeled with a fluorescent dye, and the fluorescence intensity is measured under a fluorescence microscope. There is a direct method in which an antibody labeled with a fluorescent dye is reacted directly, and an indirect method in which the antibody is reacted with an antigen and then a secondary reaction is performed with an antibody labeled with a fluorescent dye.
Less than 10 (times)
EB virus Anti-EBNA
Serum
0.2
S09 ↓ A00
3-5
FA (fluorescent antibody method)
FA (Fluorescent antibody method) Fluorescent antibody method A method in which an antigen-antibody reaction is performed against the target antigen using an antibody labeled with a fluorescent dye, and the fluorescence intensity is measured under a fluorescence microscope. There is a direct method in which an antibody labeled with a fluorescent dye is reacted directly, and an indirect method in which the antibody is reacted with an antigen and then a secondary reaction is performed with an antibody labeled with a fluorescent dye.
Less than 10 (times)
EB virus Anti-EBNA IgG
Serum
0.2
S09 ↓ A00
2-4
Enzyme immunoassay(EIA)
EIA (Enzyme immunoassay) Enzyme immunoassay The measurement principle is the same as RIA; an antigen-antibody reaction is performed using an enzyme-labeled antigen or antibody as a labeling substance, and a chromogenic substrate is added to detect enzyme activity. How to measure.
Less than 0.5 Negative Criteria: See below
Human herpesvirus type 6 DNA Qualitative
Blood (EDTA-2Na added)
2
PN5
(10 days)
3-9
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Human herpesvirus type 6 DNA Qualitative
Serum
0.7
S09 ↓ ARR
(3 month)
3-9
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Human herpesvirus type 6 DNA Qualitative
Cerebrospinal fluid
0.7
ARR
(3 month)
3-9
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Human herpesvirus type 6 DNA Qualitative
Affected area swab fluid
ARR
(3 month)
3-9
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Human herpesvirus type 6 DNA Qualitative
tissue
50mg
ARR
(3 month)
3-9
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Human herpesvirus type 6 DNA quantification
Blood (EDTA-2Na added)
5
PN7
2-4
PCR (Real Time PCR)
Real-time PCR A type of nucleic acid amplification method based on the basic principle of PCR, which uses oligonucleotides that emit fluorescence upon decomposition to quantify target nucleic acids in real time by checking the fluorescent signal at each PCR cycle. A measurement method that enables
Less than 2.0×101 (copy/106cells)
Human herpesvirus type 7 DNA Qualitative
Blood (EDTA-2Na added)
2
PN5
(10 days)
3-9
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Human herpesvirus type 7 DNA Qualitative
Serum
0.7
S09 ↓ ARR
(3 month)
3-9
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Human herpesvirus type 7 DNA Qualitative
Cerebrospinal fluid
0.7
ARR
(3 month)
3-9
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Human herpesvirus type 7 DNA Qualitative
Affected area swab fluid
ARR
(3 month)
3-9
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Human herpesvirus type 7 DNA Qualitative
tissue
50mg
ARR
(3 month)
3-9
PCR
PCR (Polymerase chain reaction) Uses the fact that DNA dissociates from double strands to single strands when heated and returns to double strands when cooled, and binds the desired primer using single stranded DNA as a template. A method in which the target DNA region is exponentially amplified by repeatedly performing DNA synthesis using the transcription reaction of DNA polymerase.
Negative
Enterovirus type 70
Serum
0.2
S09 ↓ A00
6-19
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
Enterovirus type 71
Serum
0.2
S09 ↓ A00
6-19
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
Coxsackie virus Group A, type 2
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
Coxsackie virus Group A, type 3
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
Coxsackie virus Group A, type 4
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
Coxsackie virus Group A, type 5
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
Coxsackie virus Group A, type 6
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
Coxsackie virus Group A, type 7
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
Coxsackie virus Group A, type 9
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
Coxsackie virus Group A, type 9
Serum
0.3
S09 ↓ A00
4-6
CF (complement fixation reaction)
CF (Complement fixation) Complement fixation reaction A method that utilizes the fact that complement binds to antigen-antibody complexes and causes a hemolytic reaction. Sensitized red blood cells with hemolysin bound to red blood cells cause hemolysis when complement binds to them, but if antigen-antibody complexes are present, complement is consumed and hemolysis is prevented. Determine existence.
Less than 4(times)
Coxsackie virus Group A, type 10
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
Coxsackie virus Group A, type 16
Serum
0.2
S09 ↓ A00
7-13
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(times)
Coxsackie virus Group B, type 1
Serum
0.2
S09 ↓ A00
7-13
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(times)
Coxsackie virus Group B, type 1
Serum
0.3
S09 ↓ A00
4-6
CF (complement fixation reaction)
CF (Complement fixation) Complement fixation reaction A method that utilizes the fact that complement binds to antigen-antibody complexes and causes a hemolytic reaction. Sensitized red blood cells with hemolysin bound to red blood cells cause hemolysis when complement binds to them, but if antigen-antibody complexes are present, complement is consumed and hemolysis is prevented. Determine existence.
Less than 4(times)
Coxsackie virus Group B, type 2
Serum
0.2
S09 ↓ A00
7-13
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(times)
Coxsackie virus Group B, type 2
Serum
0.3
S09 ↓ A00
4-6
CF (complement fixation reaction)
CF (Complement fixation) Complement fixation reaction A method that utilizes the fact that complement binds to antigen-antibody complexes and causes a hemolytic reaction. Sensitized red blood cells with hemolysin bound to red blood cells cause hemolysis when complement binds to them, but if antigen-antibody complexes are present, complement is consumed and hemolysis is prevented. Determine existence.
Less than 4(times)
Coxsackie virus Group B, type 3
Serum
0.2
S09 ↓ A00
7-13
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(times)
Coxsackie virus Group B, type 3
Serum
0.3
S09 ↓ A00
4-6
CF (complement fixation reaction)
CF (Complement fixation) Complement fixation reaction A method that utilizes the fact that complement binds to antigen-antibody complexes and causes a hemolytic reaction. Sensitized red blood cells with hemolysin bound to red blood cells cause hemolysis when complement binds to them, but if antigen-antibody complexes are present, complement is consumed and hemolysis is prevented. Determine existence.
Less than 4(times)
Coxsackie virus Group B, type 4
Serum
0.2
S09 ↓ A00
7-13
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(times)
Coxsackie virus Group B, type 4
Serum
0.3
S09 ↓ A00
4-6
CF (complement fixation reaction)
CF (Complement fixation) Complement fixation reaction A method that utilizes the fact that complement binds to antigen-antibody complexes and causes a hemolytic reaction. Sensitized red blood cells with hemolysin bound to red blood cells cause hemolysis when complement binds to them, but if antigen-antibody complexes are present, complement is consumed and hemolysis is prevented. Determine existence.
Less than 4(times)
Coxsackie virus Group B, type 5
Serum
0.2
S09 ↓ A00
7-13
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(times)
Coxsackie virus Group B, type 5
Serum
0.3
S09 ↓ A00
4-6
CF (complement fixation reaction)
CF (Complement fixation) Complement fixation reaction A method that utilizes the fact that complement binds to antigen-antibody complexes and causes a hemolytic reaction. Sensitized red blood cells with hemolysin bound to red blood cells cause hemolysis when complement binds to them, but if antigen-antibody complexes are present, complement is consumed and hemolysis is prevented. Determine existence.
Less than 4(times)
Coxsackie virus Group B, type 6
Serum
0.2
S09 ↓ A00
7-13
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(times)
Coxsackie virus Group B, type 6
Serum
0.3
S09 ↓ A00
4-6
CF (complement fixation reaction)
CF (Complement fixation) Complement fixation reaction A method that utilizes the fact that complement binds to antigen-antibody complexes and causes a hemolytic reaction. Sensitized red blood cells with hemolysin bound to red blood cells cause hemolysis when complement binds to them, but if antigen-antibody complexes are present, complement is consumed and hemolysis is prevented. Determine existence.
Less than 4(times)
ECHO virus type 1
Serum
0.2
S09 ↓ A00
7-18
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
ECHO virus type 3
Serum
0.2
S09 ↓ A00
7-18
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
ECHO virus type 4
Serum
0.2
S09 ↓ A00
7-18
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
ECHO virus type 5
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
ECHO virus type 6
Serum
0.2
S09 ↓ A00
7-18
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
ECHO virus type 7
Serum
0.2
S09 ↓ A00
7-18
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
ECHO virus type 9
Serum
0.2
S09 ↓ A00
7-11
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(times)
ECHO virus type 11
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
ECHO virus type 12
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
ECHO virus type 13
Serum
0.2
S09 ↓ A00
7-18
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
ECHO virus type 14
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
ECHO virus type 16
Serum
0.2
S09 ↓ A00
5-18
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
ECHO virus type 17
Serum
0.2
S09 ↓ A00
7-18
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
ECHO virus type 18
Serum
0.2
S09 ↓ A00
5-18
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
ECHO virus type 19
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
ECHO virus type 21
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
ECHO virus (Parechovirus type 1) type 22
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
ECHO virus type 24
Serum
0.2
S09 ↓ A00
7-20
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
ECHO virus type 25
Serum
0.2
S09 ↓ A00
7-18
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
ECHO virus type 30
Serum
0.2
S09 ↓ A00
7-18
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(X)
Japanese encephalitis virus(JaGAr strains)
Serum
0.5
S09 ↓ A00
4-7
Hemagglutination inhibition(HI)
HI (Hemagglutination inhibition) Hemagglutination inhibition reaction A method that utilizes the fact that the hemagglutination ability of viruses is inhibited by antibodies against the virus. The antigen-antibody complex is reacted with red blood cells, and the presence of antibodies against the virus is determined by the presence or absence of inhibition of agglutination.
JaGAr: less than 10 JaGAr 2ME: less than 10 (times)
Japanese encephalitis virus
Serum
0.3
S09 ↓ A00
4-6
CF (complement fixation reaction)
CF (Complement fixation) Complement fixation reaction A method that utilizes the fact that complement binds to antigen-antibody complexes and causes a hemolytic reaction. Sensitized red blood cells with hemolysin bound to red blood cells cause hemolysis when complement binds to them, but if antigen-antibody complexes are present, complement is consumed and hemolysis is prevented. Determine existence.
Less than 4(times)
Rubella virus
Serum
0.2
S09 ↓ A00
3-5
Hemagglutination inhibition(HI)
HI (Hemagglutination inhibition) Hemagglutination inhibition reaction A method that utilizes the fact that the hemagglutination ability of viruses is inhibited by antibodies against the virus. The antigen-antibody complex is reacted with red blood cells, and the presence of antibodies against the virus is determined by the presence or absence of inhibition of agglutination.
Less than 8 (times)
Rubella virus IgG
Serum
0.2
S09 ↓ A00
2-4
Enzyme immunoassay(EIA)
EIA (Enzyme immunoassay) Enzyme immunoassay The measurement principle is the same as RIA; an antigen-antibody reaction is performed using an enzyme-labeled antigen or antibody as a labeling substance, and a chromogenic substrate is added to detect enzyme activity. How to measure.
Less than 2.0 Negative Criteria: See below
Rubella virus IgM
Serum
0.2
S09 ↓ A00
2-4
Enzyme immunoassay(EIA)
EIA (Enzyme immunoassay) Enzyme immunoassay The measurement principle is the same as RIA; an antigen-antibody reaction is performed using an enzyme-labeled antigen or antibody as a labeling substance, and a chromogenic substrate is added to detect enzyme activity. How to measure.
Less than 0.80 Negative Criteria: See below
Influenza virus type A (H1N1)(H3N2)
Serum
0.2
S09 ↓ A00
3-5
Hemagglutination inhibition(HI)
HI (Hemagglutination inhibition) Hemagglutination inhibition reaction A method that utilizes the fact that the hemagglutination ability of viruses is inhibited by antibodies against the virus. The antigen-antibody complex is reacted with red blood cells, and the presence of antibodies against the virus is determined by the presence or absence of inhibition of agglutination.
Type A (H1N1) Less than 10 Type A (H3N2) Less than 10 (times)
Influenza virus type A
Serum
0.3
S09 ↓ A00
4-6
CF (complement fixation reaction)
CF (Complement fixation) Complement fixation reaction A method that utilizes the fact that complement binds to antigen-antibody complexes and causes a hemolytic reaction. Sensitized red blood cells with hemolysin bound to red blood cells cause hemolysis when complement binds to them, but if antigen-antibody complexes are present, complement is consumed and hemolysis is prevented. Determine existence.
Less than 4(times)
Influenza virus type B
Serum
0.2
S09 ↓ A00
3-5
Hemagglutination inhibition(HI)
HI (Hemagglutination inhibition) Hemagglutination inhibition reaction A method that utilizes the fact that the hemagglutination ability of viruses is inhibited by antibodies against the virus. The antigen-antibody complex is reacted with red blood cells, and the presence of antibodies against the virus is determined by the presence or absence of inhibition of agglutination.
B-1 Less than 10 B-2 Less than 10 (times)
Influenza virus type B
Serum
0.3
S09 ↓ A00
4-6
CF (complement fixation reaction)
CF (Complement fixation) Complement fixation reaction A method that utilizes the fact that complement binds to antigen-antibody complexes and causes a hemolytic reaction. Sensitized red blood cells with hemolysin bound to red blood cells cause hemolysis when complement binds to them, but if antigen-antibody complexes are present, complement is consumed and hemolysis is prevented. Determine existence.
Less than 4(times)
parainfluenza virus type 1
Serum
0.2
S09 ↓ A00
3-5
Hemagglutination inhibition(HI)
HI (Hemagglutination inhibition) Hemagglutination inhibition reaction A method that utilizes the fact that the hemagglutination ability of viruses is inhibited by antibodies against the virus. The antigen-antibody complex is reacted with red blood cells, and the presence of antibodies against the virus is determined by the presence or absence of inhibition of agglutination.
Less than 10 (times)
parainfluenza virus type 2
Serum
0.2
S09 ↓ A00
3-5
Hemagglutination inhibition(HI)
HI (Hemagglutination inhibition) Hemagglutination inhibition reaction A method that utilizes the fact that the hemagglutination ability of viruses is inhibited by antibodies against the virus. The antigen-antibody complex is reacted with red blood cells, and the presence of antibodies against the virus is determined by the presence or absence of inhibition of agglutination.
Less than 10 (times)
parainfluenza virus type 3
Serum
0.2
S09 ↓ A00
3-5
Hemagglutination inhibition(HI)
HI (Hemagglutination inhibition) Hemagglutination inhibition reaction A method that utilizes the fact that the hemagglutination ability of viruses is inhibited by antibodies against the virus. The antigen-antibody complex is reacted with red blood cells, and the presence of antibodies against the virus is determined by the presence or absence of inhibition of agglutination.
Less than 10 (times)
RS virus
Serum
0.3
S09 ↓ A00
4-6
CF (complement fixation reaction)
CF (Complement fixation) Complement fixation reaction A method that utilizes the fact that complement binds to antigen-antibody complexes and causes a hemolytic reaction. Sensitized red blood cells with hemolysin bound to red blood cells cause hemolysis when complement binds to them, but if antigen-antibody complexes are present, complement is consumed and hemolysis is prevented. Determine existence.
Less than 4(times)
RS virus
Serum
0.2
S09 ↓ A00
7-11
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(times)
Measles virus
Serum
0.2
S09 ↓ A00
7-11
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(times)
Measles virus IgG
Serum
0.2
S09 ↓ A00
2-4
Enzyme immunoassay(EIA)
EIA (Enzyme immunoassay) Enzyme immunoassay The measurement principle is the same as RIA; an antigen-antibody reaction is performed using an enzyme-labeled antigen or antibody as a labeling substance, and a chromogenic substrate is added to detect enzyme activity. How to measure.
Less than 2.0 Negative Criteria: See below
Measles virus IgM
Serum
0.2
S09 ↓ A00
2-4
Enzyme immunoassay(EIA)
EIA (Enzyme immunoassay) Enzyme immunoassay The measurement principle is the same as RIA; an antigen-antibody reaction is performed using an enzyme-labeled antigen or antibody as a labeling substance, and a chromogenic substrate is added to detect enzyme activity. How to measure.
Less than 0.80 Negative Criteria: See below
Mumps virus
Serum
0.2
S09 ↓ A00
3-5
Hemagglutination inhibition(HI)
HI (Hemagglutination inhibition) Hemagglutination inhibition reaction A method that utilizes the fact that the hemagglutination ability of viruses is inhibited by antibodies against the virus. The antigen-antibody complex is reacted with red blood cells, and the presence of antibodies against the virus is determined by the presence or absence of inhibition of agglutination.
Less than 8 (times)
Mumps virus
Serum
0.2
S09 ↓ A00
7-13
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that utilizes the fact that a virus loses its infectivity (neutralization) due to a reaction with antibodies against the virus. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(times)
Mumps virus
Serum
0.3
S09 ↓ A00
4-6
CF (complement fixation reaction)
CF (Complement fixation) Complement fixation reaction A method that utilizes the fact that complement binds to antigen-antibody complexes and causes a hemolytic reaction. Sensitized red blood cells with hemolysin bound to red blood cells cause hemolysis when complement binds to them, but if antigen-antibody complexes are present, complement is consumed and hemolysis is prevented. Determine existence.
Less than 4(times)
Mumps virus IgG
Serum
0.2
S09 ↓ A00
2-4
Enzyme immunoassay(EIA)
EIA (Enzyme immunoassay) Enzyme immunoassay The measurement principle is the same as RIA; an antigen-antibody reaction is performed using an enzyme-labeled antigen or antibody as a labeling substance, and a chromogenic substrate is added to detect enzyme activity. How to measure.
Less than 2.0 Negative Criteria: See below
Mumps virus IgM
Serum
0.2
S09 ↓ A00
2-4
Enzyme immunoassay(EIA)
EIA (Enzyme immunoassay) Enzyme immunoassay The measurement principle is the same as RIA; an antigen-antibody reaction is performed using an enzyme-labeled antigen or antibody as a labeling substance, and a chromogenic substrate is added to detect enzyme activity. How to measure.
Less than 0.80 Negative Criteria: See below
HTLV-I (ATLV) antibody
Serum
0.5
S09 ↓ A00
(21 days)
2-4
CLEIA
CLEIA (Chemiluminescent enzyme immunoassay) Chemiluminescent enzyme immunoassay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is subjected to a secondary reaction with the antigen, and a chemiluminescent substrate is added. method to measure luminescence intensity.
Negative
HTLV-1 antibody
Serum
0.2
S09 ↓ A00
(28 days)
3-5
Line blotting (LIA method)
A method in which an antigen is mechanically spotted on Mablen, reacted with a specific antibody against the antigen, and then subjected to a secondary reaction with an enzyme-labeled antibody to detect the antibody.
Negative Criteria: See below
HTLV-1 nucleic acid detection Qualitative
Blood (EDTA-2Na added)
7.0
PN7
(14 days)
10-16
PCR (Real Time PCR)
Real-time PCR A type of nucleic acid amplification method based on the basic principle of PCR, which uses oligonucleotides that emit fluorescence upon decomposition to quantify target nucleic acids in real time by checking the fluorescent signal at each PCR cycle. A measurement method that enables
Negative (no provirus detected)
HTLV-1 Provirus DNA qualitative
Blood (EDTA-2Na added)
7
PN7
(14 days)
10-16
PCR (Real Time PCR)
Real-time PCR A type of nucleic acid amplification method based on the basic principle of PCR, which uses oligonucleotides that emit fluorescence upon decomposition to quantify target nucleic acids in real time by checking the fluorescent signal at each PCR cycle. A measurement method that enables
Negative (no provirus detected)
HTLV-1 Provirus DNA qualitative
tissue
50mg
ARR
10-16
PCR (Real Time PCR)
Real-time PCR A type of nucleic acid amplification method based on the basic principle of PCR, which uses oligonucleotides that emit fluorescence upon decomposition to quantify target nucleic acids in real time by checking the fluorescent signal at each PCR cycle. A measurement method that enables
Negative (no provirus detected)
HTLV-I (ATLV) Provirus DNA (Clonality)
Blood (EDTA-2Na added)
7
PN7
(10 days)
17-23
Southern Blot Hybridization
Southern Blot Hybridization A technique to detect a specific gene by the following procedures: After restriction enzyme digestion of DNA, DNA is isolated and denatured to a single-stranded form with electrophoresis. Using capillary action, the singlestranded DNA is transferred to a nylon membrane and hybridized with a target probe to detect the target gene. This technique is used for analysis of abnormal changes in DNA in a quantitative and qualitative manner.
HTLV-I (ATLV) Provirus DNA (Clonality)
tissue
250mg
ARR
(1 month)
17-23
Southern Blot Hybridization
Southern Blot Hybridization A technique to detect a specific gene by the following procedures: After restriction enzyme digestion of DNA, DNA is isolated and denatured to a single-stranded form with electrophoresis. Using capillary action, the singlestranded DNA is transferred to a nylon membrane and hybridized with a target probe to detect the target gene. This technique is used for analysis of abnormal changes in DNA in a quantitative and qualitative manner.
HIV-1 RNA quantitative
Plasma
1.8
PSF
(22 days)
3-5
RT-PCR (Real Time PCR)
Real-time PCR A type of nucleic acid amplification method based on the basic principle of PCR, which uses oligonucleotides that emit fluorescence upon decomposition to quantify target nucleic acids in real time by checking the fluorescent signal at each PCR cycle. A measurement method that enables
Not detected (copy/mL)
HIV-1/2 specific antibody
Serum
0.5
S09 ↓ A00
(7 days)
3-5
immunochromatographic method
The antigen or antibody in the sample and the labeled antibody or labeled antigen labeled with colloidal gold particles move on the membrane filter while forming an immune complex, and the antibody or antigen that has been immobilized on the membrane filter in advance moves. A detection method in which immune complexes are captured, colored, and the results are determined visually.
Negative
HIV antigen/antibody
Serum
0.6
S09 ↓ A00
2-4
CLEIA
CLEIA (Chemiluminescent enzyme immunoassay) Chemiluminescent enzyme immunoassay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is subjected to a secondary reaction with the antigen, and a chemiluminescent substrate is added. method to measure luminescence intensity.
Negative
Norovirus antigen
Feces
0.5g
F00
2-8
ELISA
ELISA (Enzyme-Linked immunosorbent assay) Enzyme-linked immunosorbent assay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is reacted with the antigen secondarily, and a chromogenic substrate is added. A method of measuring enzyme activity.
Negative
Norovirus RNA qualitative
Feces
0.5g
F00
(7 days)
2-8
RT-PCR (Real Time PCR)
Real-time PCR A type of nucleic acid amplification method based on the basic principle of PCR, which uses oligonucleotides that emit fluorescence upon decomposition to quantify target nucleic acids in real time by checking the fluorescent signal at each PCR cycle. A measurement method that enables
Not detected
Dengue virus NS1 antigen
Serum
0.2
S09 ↓ A00
2-8
ELISA
ELISA (Enzyme-Linked immunosorbent assay) Enzyme-linked immunosorbent assay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is reacted with the antigen secondarily, and a chromogenic substrate is added. A method of measuring enzyme activity.
Enzyme-antibody method A method in which an antigen-antibody reaction is performed against the target antigen using an enzyme-labeled antibody, and a chromogenic substrate is added to measure the enzyme activity. There are two methods: a direct method in which an enzyme-labeled antibody reacts directly with the antigen, and an indirect method in which an unlabeled antibody reacts with the antigen followed by a secondary reaction with an enzyme-labeled antibody.
Poliovirus type 3(Suspended beyond orders placed 12-01-2016)
Serum
0.2
S09 ↓ A00
3-5
CF (complement fixation reaction)
CF (Complement fixation) A method using the fact that complement binds to antigen-antibody complexes and induces hemolytic reaction. While sensitized red blood cells, which are red blood cells bound by hemolysin, induce hemolysis when bound by complement, the presence of antigen-antibody complexes inhibits hemolysis by consuming complement, making the degree of hemolysis useful in determining the presence of antibodies.
Less than 4(x)
Poliovirus type 2(Suspended beyond orders placed 03-29-2019)
Serum
0.2
S09 ↓ A00
7-13
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that takes advantage of the fact that viruses lose infectivity (neutralization) due to their reaction with antibodies against viruses. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(x)
Poliovirus type 3(Suspended beyond orders placed 03-29-2019)
Serum
0.2
S09 ↓ A00
7-13
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that takes advantage of the fact that viruses lose infectivity (neutralization) due to their reaction with antibodies against viruses. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
ELISA (Enzyme-Linked immunosorbent assay) A method in which after reacting an antigen with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, and the enzyme activity is measured by adding a chromogenic substrate.
Negative
HIV Screening(Suspended beyond orders placed 03-31-2021)
Serum and plasma
S09 ↓ A00 and PSF
and
3-12
HIV antigen/antibody: CLEIA HIV-1 RNA quantitative: RT-PCR (Real-time PCR)
HIV antigen/antibody negative HIV-1 RNA quantitative Not detected (copy/mL)
Western blot method A method for detecting target proteins by electrophoretic fractionation of target proteins, electrically transferring them to a nitrocellulose membrane, reacting with an antibody against the target protein, and then performing a secondary reaction with an antibody labeled with an enzyme. Also called the immunoblot method.
Western blot method A method for detecting target proteins by electrophoretic fractionation of target proteins, electrically transferring them to a nitrocellulose membrane, reacting with an antibody against the target protein, and then performing a secondary reaction with an antibody labeled with an enzyme. Also called the immunoblot method.
RT-PCR (Reverse transcriptase-polymerase chain reaction) A method of PCR in which complementary cDNA is synthesized using reverse transcriptase (RT) using RNA as a template when RNA is the target of amplification.
RT-PCR (Reverse transcriptase-polymerase chain reaction) A method of PCR in which complementary cDNA is synthesized using reverse transcriptase (RT) using RNA as a template when RNA is the target of amplification.
RT-PCR (Reverse transcriptase-polymerase chain reaction) A method of PCR in which complementary cDNA is synthesized using reverse transcriptase (RT) using RNA as a template when RNA is the target of amplification.
RT-PCR (Reverse transcriptase-polymerase chain reaction) A method of PCR in which complementary cDNA is synthesized using reverse transcriptase (RT) using RNA as a template when RNA is the target of amplification.
Influenza virus type A negative Influenza virus type B negative
RT-PCR (Reverse transcriptase-polymerase chain reaction) A method of PCR in which complementary cDNA is synthesized using reverse transcriptase (RT) using RNA as a template when RNA is the target of amplification.
Influenza virus type A negative Qualitative Influenza virus type B negative TEISEI
Influenza virus type A negative Influenza virus type B negative
Japanese Encephalitis Virus RNA Qualitative(Suspended beyond orders placed 09-02-2021)
Cerebrospinal fluid
0.5
ARR
(3 months)
7-11
RT-PCR
RT-PCR (Reverse transcriptase-polymerase chain reaction) A method of PCR in which complementary cDNA is synthesized using reverse transcriptase (RT) using RNA as a template when RNA is the target of amplification.
Negative
Echovirus type 7(Suspended beyond orders placed 12-03-2020)
Serum
0.2
S09 ↓ A00
3-5
Hemagglutination inhibition(HI)
HI (Hemagglutination inhibition) Hemagglutination inhibition reaction A method that utilizes the fact that the red blood cell agglutination ability of viruses is inhibited by antibodies against the virus. The antigen-antibody complex is reacted with red blood cells, and the presence of antibodies against the virus is determined by the presence or absence of inhibition of agglutination.
Adenovirus type 8(Suspended beyond orders placed 08-09-2023)
Serum
0.2
S09 ↓ A00
7-13
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that takes advantage of the fact that viruses lose infectivity (neutralization) due to their reaction with antibodies against viruses. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
ELISA (Enzyme-Linked immunosorbent assay) A method in which after reacting an antigen with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, and the enzyme activity is measured by adding a chromogenic substrate.
Human herpesvirus type 6 IgM(Suspended beyond orders placed 03-31-2021)
Serum
0.2
S09 ↓ A00
3-5
FA (fluorescent antibody method)
FA (Fluorescent antibody method) Fluorescent antibody method A method in which an antigen-antibody reaction is performed using an antibody labeled with a fluorescent dye against the antigen of interest, and the fluorescence intensity is measured under a fluorescence microscope. There are two methods: a direct method in which an antibody labeled with a fluorescent dye reacts directly with an antigen, and an indirect method in which an antibody reacts with an antigen, followed by a secondary reaction with an antibody labeled with a fluorescent dye.
Less than 10 (x)
Human herpesvirus type 6 IgG(Suspended beyond orders placed 03-31-2021)
Serum
0.2
S09 ↓ A00
3-5
FA (fluorescent antibody method)
FA (Fluorescent antibody method) Fluorescent antibody method A method in which an antigen-antibody reaction is performed using an antibody labeled with a fluorescent dye against the antigen of interest, and the fluorescence intensity is measured under a fluorescence microscope. There are two methods: a direct method in which an antibody labeled with a fluorescent dye reacts directly with an antigen, and an indirect method in which an antibody reacts with an antigen, followed by a secondary reaction with an antibody labeled with a fluorescent dye.
Real-time PCR It is a type of nucleic acid amplification methods based on PCR method as the basic principle, which is a measurement method that, by using oligonucleotides that emit fluorescence when degraded, enables quantitative of target nucleic acids in real time by confirming the fluorescence signals in each PCR cycle.
Real-time PCR It is a type of nucleic acid amplification methods based on PCR method as the basic principle, which is a measurement method that, by using oligonucleotides that emit fluorescence when degraded, enables quantitative of target nucleic acids in real time by confirming the fluorescence signals in each PCR cycle.
Real-time PCR It is a type of nucleic acid amplification methods based on PCR method as the basic principle, which is a measurement method that, by using oligonucleotides that emit fluorescence when degraded, enables quantitative of target nucleic acids in real time by confirming the fluorescence signals in each PCR cycle.
RT-PCR (Reverse transcriptase-polymerase chain reaction) A method of PCR in which complementary cDNA is synthesized using reverse transcriptase (RT) using RNA as a template when RNA is the target of amplification.
RT-PCR (Reverse transcriptase-polymerase chain reaction) A method of PCR in which complementary cDNA is synthesized using reverse transcriptase (RT) using RNA as a template when RNA is the target of amplification.
Echovirus type 3(Suspended beyond orders placed 12-03-2020)
Serum
0.2
S09 ↓ A00
3-5
Hemagglutination inhibition(HI)
HI (Hemagglutination inhibition) Hemagglutination inhibition reaction A method that utilizes the fact that the red blood cell agglutination ability of viruses is inhibited by antibodies against the virus. The antigen-antibody complex is reacted with red blood cells, and the presence of antibodies against the virus is determined by the presence or absence of inhibition of agglutination.
Less than 8 (x)
Echovirus type 11(Suspended beyond orders placed 12-03-2020)
Serum
0.2
S09 ↓ A00
3-5
Hemagglutination inhibition(HI)
HI (Hemagglutination inhibition) Hemagglutination inhibition reaction A method that utilizes the fact that the red blood cell agglutination ability of viruses is inhibited by antibodies against the virus. The antigen-antibody complex is reacted with red blood cells, and the presence of antibodies against the virus is determined by the presence or absence of inhibition of agglutination.
Less than 8 (x)
Echovirus type 12(Suspended beyond orders placed 12-03-2020)
Serum
0.2
S09 ↓ A00
3-5
Hemagglutination inhibition(HI)
HI (Hemagglutination inhibition) Hemagglutination inhibition reaction A method that utilizes the fact that the red blood cell agglutination ability of viruses is inhibited by antibodies against the virus. The antigen-antibody complex is reacted with red blood cells, and the presence of antibodies against the virus is determined by the presence or absence of inhibition of agglutination.
HI (Hemagglutination inhibition) Hemagglutination inhibition reaction A method that utilizes the fact that the red blood cell agglutination ability of viruses is inhibited by antibodies against the virus. The antigen-antibody complex is reacted with red blood cells, and the presence of antibodies against the virus is determined by the presence or absence of inhibition of agglutination.
RT-PCR (Reverse transcriptase-polymerase chain reaction) A method of PCR in which complementary cDNA is synthesized using reverse transcriptase (RT) using RNA as a template when RNA is the target of amplification.
RT-PCR (Reverse transcriptase-polymerase chain reaction) A method of PCR in which complementary cDNA is synthesized using reverse transcriptase (RT) using RNA as a template when RNA is the target of amplification.
PA (Particle agglutination) Particle aggregation reaction A method to determine the presence of antibody or antigen by performing antigen-antibody reaction using gelatin particles, etc. (sensitized particles) to which antigen or antibody is adsorbed (bound) and the presence or absence of aggregation due to antigen-antibody reaction.
Real-time PCR It is a type of nucleic acid amplification methods based on PCR method as the basic principle, which is a measurement method that, by using oligonucleotides that emit fluorescence when degraded, enables quantitative of target nucleic acids in real time by confirming the fluorescence signals in each PCR cycle.
Real-time PCR It is a type of nucleic acid amplification methods based on PCR method as the basic principle, which is a measurement method that, by using oligonucleotides that emit fluorescence when degraded, enables quantitative of target nucleic acids in real time by confirming the fluorescence signals in each PCR cycle.
CLEIA (Chemiluminescent enzyme immunoassay) A method in which an antigen is reacted with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, a chemiluminescent substrate is added and the luminescence intensity is measured.
Real-time PCR It is a type of nucleic acid amplification methods based on PCR method as the basic principle, which is a measurement method that, by using oligonucleotides that emit fluorescence when degraded, enables quantitative of target nucleic acids in real time by confirming the fluorescence signals in each PCR cycle.
Not detected (コピー/mL)
EB viral DNA quantification(Suspended beyond orders placed 01-31-2019)
Blood (EDTA-2Na added)
5.0
PN7
(10 days)
2-4
PCR (Real Time PCR)
Real-time PCR It is a type of nucleic acid amplification methods based on PCR method as the basic principle, which is a measurement method that, by using oligonucleotides that emit fluorescence when degraded, enables quantitative of target nucleic acids in real time by confirming the fluorescence signals in each PCR cycle.
Less than 2.0×101(copy/106cells)
Poliovirus type 1(Suspended beyond orders placed 03-29-2019)
Serum
0.2
S09 ↓ A00
7-13
NT(Neutralization reaction)
NT (Neutralization test) Neutralization reaction A method that takes advantage of the fact that viruses lose infectivity (neutralization) due to their reaction with antibodies against viruses. After reacting the virus with the antibody, it is inoculated into cultured cells susceptible to the virus, and the presence of neutralizing antibodies is determined by the presence or absence of cytopathogenic effect (CPE).
Less than 4(x)
Poliovirus type 1(Suspended beyond orders placed 12-01-2016)
Serum
0.2
S09 ↓ A00
3-5
CF (complement fixation reaction)
CF (Complement fixation) A method using the fact that complement binds to antigen-antibody complexes and induces hemolytic reaction. While sensitized red blood cells, which are red blood cells bound by hemolysin, induce hemolysis when bound by complement, the presence of antigen-antibody complexes inhibits hemolysis by consuming complement, making the degree of hemolysis useful in determining the presence of antibodies.
Less than 4(x)
Poliovirus type 2(Suspended beyond orders placed 12-01-2016)
Serum
0.2
S09 ↓ A00
3-5
CF (complement fixation reaction)
CF (Complement fixation) A method using the fact that complement binds to antigen-antibody complexes and induces hemolytic reaction. While sensitized red blood cells, which are red blood cells bound by hemolysin, induce hemolysis when bound by complement, the presence of antigen-antibody complexes inhibits hemolysis by consuming complement, making the degree of hemolysis useful in determining the presence of antibodies.
Real-time PCR It is a type of nucleic acid amplification methods based on PCR method as the basic principle, which is a measurement method that, by using oligonucleotides that emit fluorescence when degraded, enables quantitative of target nucleic acids in real time by confirming the fluorescence signals in each PCR cycle.
PCR (Polymerase chain reaction) A method for exponentially amplifying the target DNA region by using the fact that DNA dissociates from double-stranded DNA to single-stranded DNA by heating and returns to double-stranded DNA by cooling, binding the target primer to single-stranded DNA as a template, and repeatedly performing DNA synthesis by the transcription reaction of DNA polymerase.
EIA (Enzyme Immunoassay Assay) Enzyme immunoassay The principle of measurement is the same as that of RIA. An antigen-antibody reaction is performed using an antigen or antibody labeled with an enzyme to a labeled substance, and a chromogenic substrate is added to measure enzyme activity.
0.200 or less Negative Criteria: See below
HTLV-I (ATLV) proviral DNA (pX region)(Suspended beyond orders placed 12-02-2016)
tissue
ARR
(3 months)
10-16
PCR
PCR (Polymerase chain reaction) A method for exponentially amplifying the target DNA region by using the fact that DNA dissociates from double-stranded DNA to single-stranded DNA by heating and returns to double-stranded DNA by cooling, binding the target primer to single-stranded DNA as a template, and repeatedly performing DNA synthesis by the transcription reaction of DNA polymerase.
Negative (no provirus detected)
HTLV-I (ATLV) proviral DNA (pX region)(Suspended beyond orders placed 12-02-2016)
Blood (EDTA-2Na added)
7.0
PN7
(10 days)
10-16
PCR
PCR (Polymerase chain reaction) A method for exponentially amplifying the target DNA region by using the fact that DNA dissociates from double-stranded DNA to single-stranded DNA by heating and returns to double-stranded DNA by cooling, binding the target primer to single-stranded DNA as a template, and repeatedly performing DNA synthesis by the transcription reaction of DNA polymerase.
Negative (no provirus detected)
Human papillomavirus DNA (low-risk group) (LBC)(Suspended beyond orders placed 09-02-2021)
Uterine cervix Vaginal contents Uterovaginal part
V41
(1 month)
4-10
Liquid phase (nucleic acid) hybridization
Liquid phase (nucleic acid) hybridization A method in which rRNA is released in the liquid phase and hybridized using a DNA probe labeled with a chemiluminescent substance, and in which the hybrid is adsorbed on the separation agent and subsequently detected by chemiluminescence.
ELISA (Enzyme-Linked immunosorbent assay) A method in which after reacting an antigen with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, and the enzyme activity is measured by adding a chromogenic substrate.
Negative
Cytomegalovirus DNA quantification(Suspended beyond orders placed 03-31-2021)
Blood (EDTA-2Na added)
5.0
PN7
(10 days)
2-4
PCR (Real Time PCR)
Real-time PCR It is a type of nucleic acid amplification methods based on PCR method as the basic principle, which is a measurement method that, by using oligonucleotides that emit fluorescence when degraded, enables quantitative of target nucleic acids in real time by confirming the fluorescence signals in each PCR cycle.
PCR (Polymerase chain reaction) A method for exponentially amplifying the target DNA region by using the fact that DNA dissociates from double-stranded DNA to single-stranded DNA by heating and returns to double-stranded DNA by cooling, binding the target primer to single-stranded DNA as a template, and repeatedly performing DNA synthesis by the transcription reaction of DNA polymerase.
PCR (Polymerase chain reaction) A method for exponentially amplifying the target DNA region by using the fact that DNA dissociates from double-stranded DNA to single-stranded DNA by heating and returns to double-stranded DNA by cooling, binding the target primer to single-stranded DNA as a template, and repeatedly performing DNA synthesis by the transcription reaction of DNA polymerase.
PCR (Polymerase chain reaction) A method for exponentially amplifying the target DNA region by using the fact that DNA dissociates from double-stranded DNA to single-stranded DNA by heating and returns to double-stranded DNA by cooling, binding the target primer to single-stranded DNA as a template, and repeatedly performing DNA synthesis by the transcription reaction of DNA polymerase.
Western blot method A method for detecting target proteins by electrophoretic fractionation of target proteins, electrically transferring them to a nitrocellulose membrane, reacting with an antibody against the target protein, and then performing a secondary reaction with an antibody labeled with an enzyme. Also called the immunoblot method.
PCR (Polymerase chain reaction) A method for exponentially amplifying the target DNA region by using the fact that DNA dissociates from double-stranded DNA to single-stranded DNA by heating and returns to double-stranded DNA by cooling, binding the target primer to single-stranded DNA as a template, and repeatedly performing DNA synthesis by the transcription reaction of DNA polymerase.
Notifications of URL changes/lab information added
You can now view test items from all labs.
Please choose a lab from the list below.
You can switch between labs as any time using the upper right lab icon.
The domain name of the TEST DIRECTORYpage has changed.
Please update bookmarks and saved links with the new address.
Notifications of URL changes/lab information added
You can now view test items from all labs.
Please choose a lab from the list below.
You can switch between labs as any time using the upper right lab icon.
The domain name of the TEST DIRECTORYpage has changed.
Please update bookmarks and saved links with the new address.